Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo- and Active-Controlled Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis
Conditions
Interventions
JTA-004
Hylan G-F 20
+1 more
Locations
22
Belgium
Cliniques universitaires Saint-Luc (UCL)
Brussels, Belgium
UZ Leuven University Hospitals Leuven
Leuven, Belgium
CHU Liège
Liège, Belgium
CHU Ambroise Paré
Mons, Belgium
CCR Brno, s.r.o
Brno, Czechia
CCR Czech, a.s
Pardubice, Czechia
Start Date
March 10, 2020
Primary Completion Date
March 31, 2021
Completion Date
December 9, 2021
Last Updated
March 2, 2022
Lead Sponsor
Bone Therapeutics S.A
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions